Background: The benefits of breastfeeding infants are well characterized, including those on the immune system. However, determining the mechanism by which human breast milk (HBM) elicits effects on immune response requires investigation in an appropriate animal model. Objective: The primary aim of this study was to develop a novel porcine model and to determine the differential effects of feeding HBM and a commercial milk formula (MF) on immune response and gastrointestinal microbial colonization in a controlled environment. Methods: Male piglets were fed HBM (n = 26) or MF (n = 26) from day 2 through day 21. Piglets were vaccinated (n = 9/diet group) with cholera toxin and cholera toxin subunit B (CTB) and tetanus toxoid at 21 d or were fed placebo (n = 6/diet group) and then weaned to a standard solid diet at the age of 21 d. Humoral and cell-mediated immune responses were assessed from blood on days 35 and 48. Immune response was further examined from tissues, including mesenteric lymph nodes (MLNs), Peyer's patches (PPs), and spleen. The colonization of gut microbiota was characterized from feces on days 16 and 49. Results: Serum antibody titers in piglets fed HBM were 4-fold higher (P < 0.05) to CTB and 3-fold higher (P < 0.05) to tetanus toxoid compared with piglets fed MF on day 48. Compared with MF, the numbers of immunoglobulin A antibody-producing cells to CTB were 13-fold higher (P < 0.05) in MLNs and 11-fold higher (P < 0.05) in PPs in the HBM diet group on day 51. In addition, significantly increased T cell proliferation was observed in the HBM group relative to the MF group. Furthermore, microbial diversity in the HBM group was lower (P < 0.05) than in the MF group. Conclusions: This porcine model appears to be valid for studying the effects of early postnatal diet on immune responses and the gastrointestinal microbiome. Our results lay the groundwork for future studies defining the role of infant diet on microbiota and immune function.
Background: The benefits of breastfeeding infants are well characterized, including those on the immune system. However, determining the mechanism by which human breast milk (HBM) elicits effects on immune response requires investigation in an appropriate animal model. Objective: The primary aim of this study was to develop a novel porcine model and to determine the differential effects of feeding HBM and a commercial milk formula (MF) on immune response and gastrointestinal microbial colonization in a controlled environment. Methods: Male piglets were fed HBM (n = 26) or MF (n = 26) from day 2 through day 21. Piglets were vaccinated (n = 9/diet group) with cholera toxin and cholera toxin subunit B (CTB) and tetanus toxoid at 21 d or were fed placebo (n = 6/diet group) and then weaned to a standard solid diet at the age of 21 d. Humoral and cell-mediated immune responses were assessed from blood on days 35 and 48. Immune response was further examined from tissues, including mesenteric lymph nodes (MLNs), Peyer's patches (PPs), and spleen. The colonization of gut microbiota was characterized from feces on days 16 and 49. Results: Serum antibody titers in piglets fed HBM were 4-fold higher (P < 0.05) to CTB and 3-fold higher (P < 0.05) to tetanus toxoid compared with piglets fed MF on day 48. Compared with MF, the numbers of immunoglobulin A antibody-producing cells to CTB were 13-fold higher (P < 0.05) in MLNs and 11-fold higher (P < 0.05) in PPs in the HBM diet group on day 51. In addition, significantly increased T cell proliferation was observed in the HBM group relative to the MF group. Furthermore, microbial diversity in the HBM group was lower (P < 0.05) than in the MF group. Conclusions: This porcine model appears to be valid for studying the effects of early postnatal diet on immune responses and the gastrointestinal microbiome. Our results lay the groundwork for future studies defining the role of infant diet on microbiota and immune function.
Authors: Thomas Thymann; Douglas G Burrin; Kelly A Tappenden; Charlotte R Bjornvad; Søren K Jensen; Per T Sangild Journal: Br J Nutr Date: 2006-06 Impact factor: 3.718
Authors: N Watemberg; R Dagan; Y Arbelli; I Belmaker; A Morag; L Hessel; B Fritzell; A Bajard; L Peyron Journal: Pediatr Infect Dis J Date: 1991-10 Impact factor: 2.129
Authors: Zhenmin Liu; Nicole C Roy; Yanhong Guo; Hongxin Jia; Leigh Ryan; Linda Samuelsson; Ancy Thomas; Jeff Plowman; Stefan Clerens; Li Day; Wayne Young Journal: J Nutr Date: 2015-12-16 Impact factor: 4.798
Authors: Fernanda Rosa; Ashok K Sharma; Manoj Gurung; David Casero; Katelin Matazel; Lars Bode; Christy Simecka; Ahmed A Elolimy; Patricia Tripp; Christopher Randolph; Timothy W Hand; Keith D Williams; Tanya LeRoith; Laxmi Yeruva Journal: Front Immunol Date: 2022-06-29 Impact factor: 8.786
Authors: Lauren R Brink; Katelin Matazel; Brian D Piccolo; Anne K Bowlin; Sree V Chintapalli; Kartik Shankar; Laxmi Yeruva Journal: J Nutr Date: 2019-12-01 Impact factor: 4.798
Authors: Eugenia Carvalho; Sean H Adams; Elisabet Børsheim; Michael L Blackburn; Kikumi D Ono-Moore; Matthew Cotter; Anne K Bowlin; Laxmi Yeruva Journal: BMC Nutr Date: 2020-04-15
Authors: Fernanda Rosa; Katelin S Matazel; Anne K Bowlin; Keith D Williams; Ahmed A Elolimy; Sean H Adams; Lars Bode; Laxmi Yeruva Journal: Front Immunol Date: 2020-12-07 Impact factor: 7.561
Authors: Laura E Carr; Misty D Virmani; Fernanda Rosa; Daniel Munblit; Katelin S Matazel; Ahmed A Elolimy; Laxmi Yeruva Journal: Front Immunol Date: 2021-02-12 Impact factor: 7.561
Authors: Fernanda Rosa; Boris L Zybailov; Galina V Glazko; Yasir Rahmatallah; Stephanie Byrum; Samuel G Mackintosh; Anne K Bowlin; Laxmi Yeruva Journal: Nutrients Date: 2021-10-22 Impact factor: 5.717
Authors: Ahmed Elolimy; Fernanda Rosa; Patricia Tripp; Mohamed Zeineldin; Anne K Bowlin; Christopher Randolph; Michael S Robeson; Laxmi Yeruva Journal: Front Microbiol Date: 2022-03-23 Impact factor: 5.640
Authors: Fernanda Rosa; Brooke Yelvington; Nathan Terry; Patricia Tripp; Hoy E Pittman; Bobby L Fay; Taylor J Ross; James D Sikes; Jessica B Flowers; Fabiana Bar-Yoseph; Laxmi Yeruva Journal: Nutrients Date: 2022-04-02 Impact factor: 5.717
Authors: Laura E Carr; Anne K Bowlin; Ahmed A Elolimy; Stephanie D Byrum; Charity L Washam; Christopher E Randolph; Stewart L MacLeod; Laxmi Yeruva Journal: Front Immunol Date: 2020-06-23 Impact factor: 7.561